SPIA
HRMY icon

Steward Partners Investment Advisory’s Harmony Biosciences HRMY Stock Holding History

Steward Partners Investment Advisory’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.76K Hold
170
– – ﹤0.01% 3815
2025
Q4 		$6.36K Hold
170
– – ﹤0.01% 3614
2025
Q3 		$4.68K Hold
170
– – ﹤0.01% 3677
2025
Q2 		$5.37K Hold
170
– – ﹤0.01% 3455
2025
Q1 		$5.64K Hold
170
– – ﹤0.01% 3344
2024
Q4 		$5.85K Hold
170
– – ﹤0.01% 3308
2024
Q3 		$6.8K Buy
+170
New +$5.97K ﹤0.01% 3094

Other funds holding HRMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Steward Partners Investment Advisory's HRMY Position: Q1 2026 in Review

Steward Partners Investment Advisory held its Harmony Biosciences (HRMY) position steady in Q1 2026 at 170 shares worth $4.76K. The position accounts for ﹤0.01% of the portfolio, ranked #3815.

Steward Partners Investment Advisory first reported a position in HRMY in Q3 2024 and has held it in 7 quarters since. The position peaked at $6.8K in Q3 2024. 309 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Steward Partners Investment Advisory held 170 shares of Harmony Biosciences worth $4.76K as of Q1 2026.
  • Steward Partners Investment Advisory left its Harmony Biosciences share count unchanged in Q1 2026.
  • Harmony Biosciences made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q1 2026, its #3815 holding.
  • Steward Partners Investment Advisory first reported a position in Harmony Biosciences in Q3 2024 and has held it in 7 quarters since.
  • Steward Partners Investment Advisory's Harmony Biosciences position peaked at $6.8K in Q3 2024.
  • 309 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q1 2026, filed 8 May 2026.